Heterozygous/hemizygous knockouts of Nf2 are cancer prone and demonstrate a tumor spectrum that differs significantly from that observed in NF-2 patients; they do not develop Schwannomas, a prominent feature of NF-2 (Giovannini et al., 2000; McClatchey et al., 1998). This evidence concerns the gene NF2 and schwannoma.